Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial

被引：12

作者：

Spratt, D. E. ^{[1
]}

Dess, R. T. ^{[1
]}

Efstathiou, J. A. ^{[2
]}

Zietman, A. L. ^{[3
]}

Wallington, D. G. ^{[4
]}

Jairath, N. K. ^{[5
]}

Jackson, W. C. ^{[1
]}

Den, R. B. ^{[6
,7
,8
]}

Stish, B. J. ^{[9
]}

Morgan, T. M. ^{[10
]}

Dignam, J. J. ^{[11
]}

Pisansky, T. M. ^{[9
]}

Rosenthal, S. A. ^{[12
]}

Michalski, J. M. ^{[13
]}

Sartor, O. ^{[14
]}

Feng, F. Y. ^{[15
]}

Schipper, M. ^{[16
]}

Sandler, H. M. ^{[17
]}

Sun, Y. ^{[18
]}

Shipley, W. U. ^{[2
]}

机构：

[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA

[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA

[3] Massachusetts Gen Hosp, Boston, MA 02114 USA

[4] Western Michigan, Ann Arbor, MI USA

[5] Univ Michigan, Ann Arbor, MI 48109 USA

[6] Sidney Kimmel Med Coll, Dept Radiat Oncol, Philadelphia, PA USA

[7] Thomas Jefferson Univ, Ctr Canc, Philadelphia, PA 19107 USA

[8] Thomas Jefferson, Philadelphia, PA USA

[9] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA

[10] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA

[11] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA

[12] Sutter Med Grp & Canc Ctr, Sacramento, CA USA

[13] Washington Univ, Sch Med, St Louis, MO USA

[14] Tulane Univ, New Orleans, LA 70118 USA

[15] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA

[16] Univ Michigan, Dept Radiat Oncol, Michigan Med, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[17] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[18] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 03期

关键词：

D O I：

10.1016/j.ijrobp.2019.08.029

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA1

引用

页码：680 / 680

页数：1

共 2 条

[1] NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA
Shipley, William U.
Pugh, Stephanie L.
Lukka, Himu R.
Major, Pierre
Heney, Niall M.
Grignon, David A.
Sartor, Oliver
Patel, Malti
Bahary, Jean -Paul
Zietman, Anthony L.
Pisanslcy, Thomas Michael
Zeitzer, Kenneth Lee
Lawton, Colleen Anne
Feng, Felix Yi-Chung
Lovett, Richard Dana
Balogh, Alexander G.
Souhami, Luis
Rosenthal, Seth A.
Kerlin, Kevin
Sandler, Howard M.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[2] Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.
Pollack, Alan
Johnson, Marla
Proudfoot, James
Davicioni, Elai
Dal Pra, Alan
Simko, Jeff
Martin, Andre-Guy
Lukka, Himanshu
Angyalfi, Steve
Michalski, Jeff M.
Duclos, Marie
Rodrigues, George B.
Lee, R. Jeffrey
Roof, Kevin S.
Jia, Angela Y.
Seaward, Samantha A.
Khaouam, Nader
Karrison, Theodore
Feng, Felix Y.
Tran, Phuoc T.
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)

← 1 →